peptide immunogenicity

Peptide Immunogenicity HLA MHC Epitope Prediction

In 1998, a reformulation of the blood-disorder drug Eprex triggered an unexpected immune response in European patients, revealing how peptide immunogenicity and HLA binding can transform a stable therapeutic into a liability.